Who owns Medicis Pharmaceutical Corporation?

Key details on Medicis Pharmaceutical Corporation (Ticker: MRX)

Who owns Medicis Pharmaceutical Corporation?

Is MRX a good stock to own? Find out who bought Medicis Pharmaceutical Corporation, who sold Medicis Pharmaceutical Corporation (MRX) stock, and who holds a large position in Medicis Pharmaceutical Corporation.

Fund Name Number of Shares Share Valuation As Of
Visium Asset Management 3.40M $127.81M March 31, 2012
Vanguard 2.99M $129.35M Sept. 30, 2012
HealthCor Management 2.45M $92.10M March 31, 2012
Standard Life Investments 2.36M $80.50M June 30, 2012
STATE STREET CORPORATION 2.33M $100.88M Sept. 30, 2012
Iridian Asset Management 2.10M $71.63M June 30, 2012
Eton Park Capital Management 2.00M $86.54M Sept. 30, 2012
Millennium Management 1.98M $85.56M Sept. 30, 2012
Palo Alto Investors 1.46M $63.08M Sept. 30, 2012
Brown Capital Management 1.39M $60.08M Sept. 30, 2012
GAMCO Asset Management 1.21M $52.36M Sept. 30, 2012
Thompson, Siegel, & Walmsley 1.18M $40.38M June 30, 2012
Ameriprise Financial 1.13M $38.43M June 30, 2012
CR Intrinsic Investors 1.12M $37.41M Dec. 31, 2011
Samlyn Capital 1000000 $34.15M June 30, 2012
UBS AG 972992 $42.10M Sept. 30, 2012
Expo Capital Management 960000 $36.09M March 31, 2012
Carlson Capital 853000 $36.91M Sept. 30, 2012
Gabelli Funds 803865 $34.78M Sept. 30, 2012
Andromeda Capital 765485 $33.11M Sept. 30, 2012
Hudson Bay Capital Management 731901 $31.67M Sept. 30, 2012
Paulson & Co 700000 $25.54M Sept. 30, 2011
JPMORGAN CHASE & CO 698877 $23.87M June 30, 2012
Paulson & Co 681400 $25.61M March 31, 2012
Columbus Circle Investors 672984 $22.98M June 30, 2012
Weintraub Capital Management 652100 $28.22M Sept. 30, 2012
Gabelli Securities 631015 $27.30M Sept. 30, 2012
ING Investment Management Co Address: 10 State House Square 590202 $19.62M Dec. 31, 2011
Renaissance Technologies 586900 $19.51M Dec. 31, 2011
Munder Capital Management 577716 $19.61M June 30, 2012
T. Rowe Price Associates 575400 $24.90M Sept. 30, 2012
Adage Capital Partners GP 569410 $24.64M Sept. 30, 2012
RoundKeep Capital Advisors 552900 $23.92M Sept. 30, 2012
Davidson Kempner Capital Management 544509 $23.56M Sept. 30, 2012
Barclays 537700 $17.88M Dec. 31, 2011
AQR Capital Management 521785 $17.35M Dec. 31, 2011
CITADEL ADVISORS 515748 $17.61M June 30, 2012
Inves 504975 $21.85M Sept. 30, 2012
Alyeska Investment 500000 $21.64M Sept. 30, 2012

Who sold Medicis Pharmaceutical Corporation?

Fund Name Date Sold Number of Shares Sold Share Valuation
FRED ALGER MANAGEMENT Sept. 30, 2011 1.33M $48.62M
Tygh Capital Management Sept. 30, 2011 569036 $20.76M
S.A.C. Capital Advisors Sept. 30, 2011 524335 $19.13M
Legg Mason Capital Management Aug. 11, 2011 572024 $21.83M
SEIZERT CAPITAL PARTNERS June 30, 2011 1.10M $41.92M
GOLDMAN SACHS June 30, 2011 652786 $24.92M
Frank Russell Company June 30, 2011 650763 $24.84M
Cambiar Investors June 30, 2011 583865 $22.29M
CI Investments June 30, 2011 510800 $19.50M
Neuberger Berman June 30, 2011 501500 $19.14M
Partner Fund Management March 31, 2011 1.78M $57.03M
Partner Investment Management March 31, 2011 940529 $30.13M
Balyasny Asset Management March 31, 2011 570000 $18.26M
Suffolk Capital Management March 31, 2011 540842 $17.33M
FMR Dec. 31, 2010 1.27M $33.96M
Oracle Investment Management Dec. 31, 2010 1.02M $27.41M
Origin Asset Management Dec. 31, 2010 664686 $17.81M
Two Sigma Investments Dec. 31, 2010 598212 $16.03M
Manulife Asset Management March 31, 2008 517908 $11.00M
Maverick Capital Sept. 30, 2004 2.19M $85.45M